Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

July 1, 2020
Review

Macular oedema associated with taxanes: A case report and literature review

Archivos de la Sociedad Española de Oftalmología
D Álvarez-FernándezC Rodríguez-Balsera
July 1, 2020
Open Access

Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on Hepatotoxicity

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
James H LewisAntoine Italiano
June 27, 2020

Perturbations of pathway co-expression network identify a core network in metastatic breast cancer

Computational Biology and Chemistry
Claudia CavaIsabella Castiglioni
July 1, 2020
Open Access

Progress in Local Treatment of Breast Cancer: A Narrative Review

Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
Francisco Pimentel CavalcanteGuilherme Garcia Novita
June 25, 2020
Open Access

Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions

BMC Research Notes
Eman Taha AliAli Mahmoud Mohammed Edris
June 25, 2020
Preprint
Open Access

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast

MedRxiv : the Preprint Server for Health Sciences
S. NagasawaYutaka Suzuki
June 26, 2020
Open Access

Clinicopathologic Characteristics of Breast Cancer According to the Infiltrating Immune Cell Subtypes

International Journal of Molecular Sciences
Hye Min Kim, Ja Seung Koo
July 1, 2020
Review

The Role of Neoadjuvant Therapy in Melanoma

Current Oncology Reports
Zahra R KellyDiwakar Davar
June 27, 2020
Open Access

Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Maria-Lisa WilhelmOliver Blanck
July 1, 2020

Multimodality Imaging Features of a Misleading Sacral Giant Cell Tumor in 18F-FDG PET/CT, Bone Scan, and MRI

Clinical Nuclear Medicine
Sebastien DejustDavid Morland
July 1, 2020

A novel mitochondrial targeted hybrid peptide modified HPMA copolymers for breast cancer metastasis suppression

Journal of Controlled Release : Official Journal of the Controlled Release Society
Qiuyi LiYuan Huang

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2020 Meta ULC. All rights reserved
/feed-previews/breast-invasive-carcinoma-keystone/7b7e0d27-792e-458e-bf22-1b7ea8eb5ad8